Bath & Body Works, Inc. (NYSE:BBWI) Position Trimmed by RWA Wealth Partners LLC

RWA Wealth Partners LLC decreased its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 6.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 32,845 shares of the company’s stock after selling 2,200 shares during the period. RWA Wealth Partners LLC’s holdings in Bath & Body Works were worth $1,418,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in BBWI. Federated Hermes Inc. grew its position in shares of Bath & Body Works by 17.1% during the fourth quarter. Federated Hermes Inc. now owns 1,612 shares of the company’s stock worth $70,000 after acquiring an additional 235 shares during the last quarter. Commonwealth Equity Services LLC grew its position in Bath & Body Works by 3.3% in the 3rd quarter. Commonwealth Equity Services LLC now owns 11,044 shares of the company’s stock valued at $373,000 after buying an additional 348 shares in the last quarter. CWM LLC lifted its holdings in Bath & Body Works by 7.3% in the 4th quarter. CWM LLC now owns 5,167 shares of the company’s stock valued at $223,000 after acquiring an additional 353 shares during the last quarter. DekaBank Deutsche Girozentrale lifted its holdings in Bath & Body Works by 1.3% in the 4th quarter. DekaBank Deutsche Girozentrale now owns 31,475 shares of the company’s stock valued at $1,349,000 after acquiring an additional 414 shares during the last quarter. Finally, Diversified Trust Co lifted its holdings in Bath & Body Works by 1.9% in the 4th quarter. Diversified Trust Co now owns 23,663 shares of the company’s stock valued at $1,021,000 after acquiring an additional 435 shares during the last quarter. Institutional investors own 95.14% of the company’s stock.

Insider Buying and Selling

In related news, insider Thomas E. Mazurek sold 4,285 shares of the firm’s stock in a transaction on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total value of $209,493.65. Following the completion of the transaction, the insider now directly owns 45,992 shares of the company’s stock, valued at $2,248,548.88. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.19% of the stock is owned by company insiders.

Bath & Body Works Trading Up 2.7 %

BBWI opened at $45.13 on Wednesday. Bath & Body Works, Inc. has a 1-year low of $27.30 and a 1-year high of $50.34. The stock has a market capitalization of $10.15 billion, a price-to-earnings ratio of 11.72, a P/E/G ratio of 1.43 and a beta of 1.86. The business has a 50 day moving average of $46.17 and a 200-day moving average of $40.36.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Thursday, February 29th. The company reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.21. Bath & Body Works had a negative return on equity of 37.01% and a net margin of 11.82%. The company had revenue of $2.91 billion during the quarter, compared to analysts’ expectations of $2.84 billion. During the same period in the prior year, the business earned $1.86 earnings per share. Bath & Body Works’s revenue for the quarter was up .8% compared to the same quarter last year. Equities analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 8th. Investors of record on Friday, February 23rd were given a $0.20 dividend. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a $0.80 annualized dividend and a yield of 1.77%. Bath & Body Works’s dividend payout ratio (DPR) is currently 20.78%.

Wall Street Analysts Forecast Growth

A number of research firms have commented on BBWI. Evercore ISI upped their price objective on shares of Bath & Body Works from $30.00 to $45.00 and gave the company an “in-line” rating in a research note on Friday, March 1st. Barclays lowered shares of Bath & Body Works from an “overweight” rating to an “equal weight” rating and upped their price objective for the company from $37.00 to $45.00 in a research note on Thursday, January 4th. Robert W. Baird upped their price objective on shares of Bath & Body Works from $50.00 to $54.00 and gave the company an “outperform” rating in a research note on Friday, March 1st. TD Cowen increased their price target on shares of Bath & Body Works from $35.00 to $55.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. Finally, Wells Fargo & Company increased their price target on shares of Bath & Body Works from $40.00 to $42.00 and gave the stock an “equal weight” rating in a research report on Friday, March 1st. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $46.33.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.